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Introduction
Qualitative urinalysis, accomplished by means of com-
mercial reagent strips, is simple, inexpensive and rapid,
but when manually performed it is based on subjective
discrimination between subtleties of hue and gradations
in opacity. Inter-observer differences in test strip inter-
pretation have been shown to be important causes of
variability of results.
The introduction of automatic analysers, based on
reflectance photometry, overcame the difficulty ofsubjec-
tive interpretation, but posed problems of sample and
data management and required more sophisticated
quality control systems.
This paper describes procedures for sample and data
management and for a specific quality control pro-
gramme.
Material and methods
Urine analysers: Automated Urine Analyser Hi-Speed
Aution Analyser Model HS-7 and Digital Urinometer
Biovation linked on line with the DP-8N Buffer memory
(all by Kyoto, Daiichi Kagaku Co. Ltd, Japan, supplied
in Italy by Menarini of Firenze).
Hardware: Display CRT Terminal DSM 6680, Minicom-
puter P6060 with a 32 KbyteROM and 400 Kbyte RAM
in floppy disks equipped with standard interface, Printer
PR 1230 (130 characters/s), and OPR 1830 Wand
Automatic Optical Reader for OCR-B characters (all by
Olivetti ing.C., Spa, Ivrea, Italy).
Reagents: Urine reagent strips Uriflet 7A DIC, Check
Sample Set (used for calibration control of Aution
analyser) and Rifra-Chek Solutions for calibration and
control of Urinometer lot 040 (all by Kyoto, Daiichi,
Kagaku Co. Ltd, distributed in Italy by Menarini of
Firenze). Urine Controls: Kova Trol 1, Kova Trol 2, and
Kova Trol 3: Human Urine (dried) manufactured by
ICL Scientific, 18349 Euclid, Fountain Valley, California
92708, USA (distributed in Italy by Boehringer Bioche-
mia Robin Diagnostic Division, Milano).
In this study, flesh urine samples from hospital and
out-patient clinics were used.
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Software
The programs in Basic were written by laboratory staff. A
complete listing of the programs is available from the
authors (see figure 1).
Figure 1. Flow chart ofurine samples and data management.
Urine samples, in cuvettes distinguished by yellow caps,
are randomly analysed as they are delivered to the
laboratory. Using the same random sequence, patient
identification numbers, printed on containers tags in
OCR-B characters, are entered in the minicomputer
automatically (optical reader) or manually (keyboard).
The seven-reagent strip (pH, glucose, protein haemoglo-
bin, ketone bodies, bilirubin and urobilinogen) dipped in
the urine specimen, is placed on the turntable of the HS-7
analyser. The strip is carried automatically to the opticalG. Barbaresi et al. Automation in urinalysis
Table 1. Scalefor reporting results ofurinary sediment examination.*
Sediment
concentration 10 Neg. Occasional + 2+ 3+ 4+
Erythrocytes 0 Less than 4 4-8 8-30 30 Packed field
(high power field) x440
White cells 0 Less than 5 5-20 20-50 50 Packed field
(high power field) x440
Casts and abnormal crystals
(low power field) x O0
0 Less than 1-5 5-10 10-30 30
* From M. Bradley et al.: Examination of urine, in Henry, J. B. Clinical Diagnosis and Management by Laboratory Methods, 16th edn (W. B.
Saunders Company, Philadelphia, London and Toronto, 1979), p. 613.
section for reflectance measurement and the results are
stored in DP-8N buffer memory.
Urine samples are then spun at 2000 r.p.m, for 5 min
using a standard bench centrifuge. The clear supernatant
(about 90% of the total specimen) is decanted in the
Urinometer for relative density (r.d.) refractometric
determination. Relative density results are also stored in
the DP-8N. When the analysis is complete the results
generated by the HS-7 and Urinometer are transferred to
the minicomputer and linked to relevant patient num-
bers.
A drop of the pellet, resuspended in the remaining
supernatant, is placed on a slide for microscopic examina-
tion. As an aid to correct interpretation of each micro-
scopic test, the respective data of pH, haemoglobin and
protein are displayed in sequence on the CRT terminal.
The findings are then fed into the minicomputer using a
three-digit codex: the first two digits identifying the
elements, and the last one quantifying them (see table 1).
At the same time, glucose and protein abnormal results
are sorted and worksheet for quantitative determinations
are printed. Quantitative results are then entered by
keyboard. Records ofcomplete urinalyses are transferred
to the hospital’s data processing centre (HDPC) by
means of a floppy disk for personalized report print-out.
Quality-control system
Quality control (see figure 2) includes inspection of the
results of urine controls at three concentration levels
analysed in the sample batch after 30 specimens, and
retrospective analysis of patient result distribution once
the analyses are complete.
Two procedures are provided for physicochemical (pH,
s.g.) and chemical parameters (glucose, albumin, haemo-
globin, ketones, urobilinogen, bilirubin). Results of
physicochemical parameter determinations are sub-
divided into 10 frequency classes. Next the percentage
frequency and the percentage cumulative frequency of
each class are calculated and logit transformed. Finally,
the patient distribution mean and 95% limits of the
normal range are obtained by a plot of logit transformed
,1
Inspection of tmine /
ocntrol results /
O].(lllaticn of pez(et
ctive %
Calculation of
Ploto loit bsfcmd
olati frequle %
(Y) upr
limits (X). Evaluation of
Isults al plot printout
Figure 2. Flow chart of quality-control procedure.
data (y) against upper class limits (x) (see figure 3). The
procedure for chemical parameters calculates the fre-
quency in per cent of normal and abnormal results.
Both procedures are applied to the hospital patients, to
the out-patients and to the cumulative results. Finally the
program prints-out all calculated parameters (see figure
3),
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Figure 3. Daily report ofurine patient result statislics. Date.
Results and discussion
Urine analysis yields a great deal of clinical information
for diagnosis and management of renal or urinary tract
diseases, and for the detection of metabolic and systemic
diseases not directly related to the kidney. Complete
urinalyses should include both biochemical and micro-
scopical findings.
The technique for qualitative urinalysis using reagent
strips is simple, inexpensive and is performed in most
clinical laboratories. Automatic analysers have recently
become available for reading reagent strips and for
refractometric determination of r.d. These commercial
analysers overcome the difficulties arising from subjective
interpretations of results and from handling large vol-
umes ofsamples. They also provide a complete personal-
ized report by input of identification data (name,
surname) and nosographic numbers. Thus using these
commercial urinalysis systems in laboratories such as the
authors’, supported by a data-bank of HDPC which
automatically daily supplies patient data, generates
additional clerical work.
The authors propose a procedure that ensures rational
employment of the analysers and supplies a complete
report without overlapping with the HDPC. Urinalysis
records are transferred, by floppy disks, to HDPC for a
personalized and complete report print-out and storage
in the central data bank.
Interesting features of the authors’ system are the
possibility ofdisplaying physicochemical parameters as a
support at the time ofmicroscopical examination and the
possibility of sorting glucose and protein pathological
results for quantitative determinations. Little work on
intra-laboratory urinalysis quality control systems has
been reported ifcompared with quality-control programs
available for other parameters in clinical chemistry, and
the literature on inter-laboratory surveys shows, generally,
a poor standard performance [1 and 2]. The reason tbr
this is the difficulty of quantifying the accuracy and the
precision of qualitative results. Reliable and stable urine
controls are commercially available and routinely
employed, but the criteria ofinterpretation oftheir results
are unsatisfactory. It is generally accepted that any
reaction grade one step higher or lower than the expected
value of urine controls is sufficient [1]. The authors’
experience indicates that this criterion alone might not
ensure effective monitoring of urinalysis performance. In
order to ensure that the urinalysis quality-control system
was reliable and sensitive, statistical analysis of patient
results was introduced, adapting control procedures
routinely used in clinical chemistry [3, 4 and 5].
The distribution of patient results should be constant
under stable analytical conditions and without popula-
tion changes. At the authors’ hospital the composition of
the out-patient population is quite constant, and so it is
possible to discriminate between the effects ofpopulation
changes and those of analytical errors by separately
considering hospitalized and out-patients. As far as the
total number of patients is concerned, it can vary from a
maximum of 300/day to a minimum of 150/day, the
number of out-patients being constant around 70/day.
The latter population is large enough not to influence the
distribution [6].
The rationale for setting the interpretation criteria of
daily patient ’distribution patterns is as follows.
For urinalysis qualitative chemical parameters it is
assumed that, in a normal population, the percentage
frequency of negative results should very close to 100%.
So, a random error higher than 5% is unacceptable, and
Table 2. Mean percentage frequency of daily negative results in
stable analytical conditions.
All patients In-patients Out-patients
Glucose 96% + 1.9 96% + 2"2 97% + 2"0
Protein 86% + 3"5 83% _+ 4.3 94% +_ 3"0
Haemoglobin 77% + 4"3 71% + 4.7 94% _+ 3’2
Bilirubin 98% + 2"0 98% + 1"6 99% + 1.1
Ketones 95% + 2"4 93% + 3"0 99% _+ 1.4
Urobilinogen 95% + 1"7 93% + 2"2 99% + 2’0
The reported values are the means _+ SD calculated from 30
daily percentage frequencies under stable analytical conditions.
the percentage frequency of daily negative results cannot
be lower than 95%. table 2 shows the mean percent-
age frequency of daily negative results for qualitative
chemical parameters obtained under stable analytical
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Figure 4. Control charts for pH and r.d. of daily out-patients’
results. The horizontal lines represent the true valuesfor both daily
means and 95% control limits. The acceptability ranges are
marked by shading.
conditions. The values for the out-patients are higher than
for the hospital patients, and greater than 95% except for
protein and haemoglobin. These findings may be
explained by physiological trace amounts of protein and
haemoglobin. Therefore, for these parameters, the mean
frequency of daily negative results should not be lower
than 90%. The percentage frequency of glucose negative
results for out-patients is similar to that of hospital
patients; a reason for this might be that hospital patients
have a controlled diet. The constancy of analytical
performance is then certified by regular behaviour of the
daily negative results frequencies into 90% and 95%
limits. For pH and r.d. it is believed that if the laboratory
testing procedure is unstable, then the limits of normal
range ofout-patient population will shift. The evaluation
of daily performance (figure 4) is accomplished by
comparing daily means and normal limits with the mean
value obtained during a period of 30 days under optimal
analytical conditions. These values are then considered
as the ’true values’ in the daily control chart. The
acceptability range (the shaded area in figure 4) is defined
as x +_ 1.96 SD both for normal limits and for the mean. It
would be impossible to adopt the standard error of the
mean (SE SD/X/N-) since this value is too small and
lower than the instrument’s resolution power. Figure 4
shows the typical behaviour of out-patients’ daily results
for pH and r.d.
The introduction of the system described in the authors’
laboratory was able to solve the problems resulting from
the urinalysis automation, concerning sample and data
management and quality control. A more rational
employment of analysers and a certified analytical
performance was achieved.
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